Precigen, Inc.PGENNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
9.17%
↓ 67% below average
Average (9y)
27.83%
Historical baseline
Range
High:182.52%
Low:-90.25%
CAGR
-26.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 9.17% |
| 2023 | 3.06% |
| 2022 | -1.59% |
| 2021 | 21.57% |
| 2020 | 0.00% |
| 2019 | -90.25% |
| 2018 | 182.52% |
| 2017 | 27.71% |
| 2016 | -23.97% |
| 2015 | 150.04% |